The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of ifupinostat (BEBT-908) in combination with rituximab for relapsed/refractory diffuse large B-cell lymphoma: Results from an exploratory phase Ib study.
 
Peng Liu
No Relationships to Disclose
 
Yufu Li
No Relationships to Disclose
 
Yajun Li
No Relationships to Disclose
 
Fang Zhu
No Relationships to Disclose
 
Ying Cheng
No Relationships to Disclose
 
Ou Bai
No Relationships to Disclose
 
Wenyu Li
No Relationships to Disclose
 
Hui Wu
No Relationships to Disclose
 
Xinquan Liang
No Relationships to Disclose
 
Yongdong Zhang
No Relationships to Disclose
 
Hongwei Xue
No Relationships to Disclose
 
Zhiming Li
No Relationships to Disclose
 
Changgeng Qian
Employment - BeBetter Med, Inc
Leadership - BeBetter Med, Inc
Stock and Other Ownership Interests - BeBetter Med, Inc
Patents, Royalties, Other Intellectual Property - BeBetter Med, Inc
 
Yuankai Shi
No Relationships to Disclose